Display options
Cite
Hernando-Cubero J, Sanz-Moncasi P, Hernández-García A, et al. Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report. Oncol Lett. 2016;12(4):2936-2941doi: 10.3892/ol.2016.4950.
Hernando-Cubero, J., Sanz-Moncasi, P., Hernández-García, A., Pajares-Bernard, I., & Martínez-Trufero, J. (2016). Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report. Oncology letters, 12(4), 2936-2941. https://doi.org/10.3892/ol.2016.4950
Hernando-Cubero, Jorge, et al. "Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report." Oncology letters vol. 12,4 (2016): 2936-2941. doi: https://doi.org/10.3892/ol.2016.4950
Hernando-Cubero J, Sanz-Moncasi P, Hernández-García A, Pajares-Bernard I, Martínez-Trufero J. Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report. Oncol Lett. 2016 Oct;12(4):2936-2941. doi: 10.3892/ol.2016.4950. Epub 2016 Aug 03. PMID: 27698882; PMCID: PMC5038563.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2016 Oct;12(4):2936-2941. doi: 10.3892/ol.2016.4950. Epub 2016 Aug 03.

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

Oncology letters

Jorge Hernando-Cubero, Pilar Sanz-Moncasi, Alba Hernández-García, Isabel Pajares-Bernard, Javier Martínez-Trufero

Affiliations

  1. Department of Medical Oncology and Pathology, University Hospital Miguel Servet, 50008 Zaragoza, Spain.

PMID: 27698882 PMCID: PMC5038563 DOI: 10.3892/ol.2016.4950

Abstract

The Ewing's sarcoma family of tumors (ESFT) comprises a number of rare malignant tumors. Standard first-line treatment for patients with these tumors includes chemotherapy with a five-drug regimen of vincristine, doxorubicin (Adriamycin

Keywords: Ewing's sarcoma; extraskeletal metastases; metastatic sarcoma; palliative chemotherapy; trabectedin

References

  1. J Clin Oncol. 2011 Jun 20;29(18):2528-33 - PubMed
  2. J Clin Oncol. 2009 Sep 1;27(25):4188-96 - PubMed
  3. Onkologie. 2012;35(5):249-52 - PubMed
  4. Eur J Cancer. 2006 Jul;42(10 ):1484-90 - PubMed
  5. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):672-7 - PubMed
  6. Clin Cancer Res. 2014 Mar 1;20(5):1190-203 - PubMed
  7. N Engl J Med. 2003 Feb 20;348(8):694-701 - PubMed
  8. Br J Cancer. 2013 Oct 1;109 (7):1717-24 - PubMed
  9. Eur J Cancer. 2012 Mar;48(4):579-85 - PubMed
  10. J Pediatr Hematol Oncol. 2009 Oct;31(10):723-9 - PubMed
  11. J Mol Diagn. 2007 Sep;9(4):459-63 - PubMed
  12. Clin Cancer Res. 2010 May 1;16(9):2656-65 - PubMed
  13. Anticancer Drugs. 2015 Jul;26(6):678-81 - PubMed
  14. J Clin Oncol. 2005 Jan 20;23 (3):576-84 - PubMed
  15. N Engl J Med. 1994 Aug 4;331(5):294-9 - PubMed
  16. J Clin Oncol. 2004 Mar 1;22(5):890-9 - PubMed
  17. Pediatr Blood Cancer. 2012 Nov;59(5):854-8 - PubMed
  18. Oncologist. 2012;17(3):321 - PubMed
  19. Mol Cancer Ther. 2010 Aug;9(8):2157-63 - PubMed
  20. J Clin Oncol. 2004 Apr 15;22(8):1480-90 - PubMed
  21. Jpn J Cancer Res. 1998 Jul;89(7):703-11 - PubMed
  22. Neoplasia. 2011 Feb;13(2):145-53 - PubMed
  23. Eur J Cancer. 2012 Nov;48(16):3036-44 - PubMed

Publication Types